DocGo (DCGO) NDR Highlights the Replacement for Covid19 Revenue - Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Richard Close reiterated a Buy rating and $10.00 price target on DocGo (NASDAQ: DCGO) after hosting management ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
